Efficacy of thymosin α1 for sepsis: a systematic review and meta-analysis of randomized controlled trials.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Efficacy of thymosin α1 for sepsis: a systematic review and meta-analysis of randomized controlled trials.
- Published In:
- Frontiers in cellular and infection microbiology, 15, 1673959 (2025)
- Authors:
- Gu, Bin, Zhou, Yu(2), Nie, Yao, Wang, Luhao, Liang, Liqun, Liao, Zihuai, Wen, Jingyi, Guan, Xiangdong, Chen, Minying, Wu, Jianfeng, Pei, Fei
- Database ID:
- RPEP-11189
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-11189APA
Gu, Bin; Zhou, Yu; Nie, Yao; Wang, Luhao; Liang, Liqun; Liao, Zihuai; Wen, Jingyi; Guan, Xiangdong; Chen, Minying; Wu, Jianfeng; Pei, Fei. (2025). Efficacy of thymosin α1 for sepsis: a systematic review and meta-analysis of randomized controlled trials.. Frontiers in cellular and infection microbiology, 15, 1673959. https://doi.org/10.3389/fcimb.2025.1673959
MLA
Gu, Bin, et al. "Efficacy of thymosin α1 for sepsis: a systematic review and meta-analysis of randomized controlled trials.." Frontiers in cellular and infection microbiology, 2025. https://doi.org/10.3389/fcimb.2025.1673959
RethinkPeptides
RethinkPeptides Research Database. "Efficacy of thymosin α1 for sepsis: a systematic review and ..." RPEP-11189. Retrieved from https://rethinkpeptides.com/research/gu-2025-efficacy-of-thymosin-1
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.